Children's Hospital of Philadelphia · company speakers →
Dr. David Teachey will provide updates on the diagnosis and management of cytokine release syndrome (CRS). This discussion will focus on similarities and differences in clinical, laboratory, and biologic manifestations of CRS based on patient population, immunotherapy target, and disease treated. Further, risk prediction models, HLH-like toxicities and novel treatment approaches, including targeting Jak/Stat and interferon gamma blockade will be reviewed.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →